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Summary Heterogeneity of DNA content in multiple hepatocellular carcinomas (HCCs) was investigated by flow cytometry in 62 tumours
from 26 patients who had undergone surgical treatment for multiple synchronous HCCs. Heterogeneity of DNA content was defined (a) when
tumours had a different DNA ploidy pattern or (b) when the difference in the DNA index of the aneuploid clone was more than 0.1. A tumour
with DNA aneuploidy was observed in 17 (66%) of the 26 patients. Heterogeneity of the DNA content was demonstrated in 12 (46%) out of 26
patients: in ten cases by definition (a) and in two cases by definition (b). Histological examination revealed that, of the 12 patients with a
heterogeneous tumour DNA content, seven (58%) had a heterogeneous and the remaining five (42%) had a homogeneous type and grade of
differentiation among the tumours, showing the absence of a-relationship between histological heterogeneity and DNA content. The present
results suggest the clinical relevance of DNA content analysis for identifying the clonal origin of multiple HCCs.
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Hepatocellular carcinoma (HCC) is the most common malignancy
in Africa and Asia and is associated with a poor prognosis.
Surgical resection is the first choice of treatment. However, the
frequent development ofmultiple tumours in patients with chronic
viral hepatitis and/or cirrhosis hinders curability. Thus, it is
thought important to understand the biological behaviour and
clonal origin of different tumours in cases of multiple HCC for
evaluation of clinical stage, prediction of post-operative outcome
and choice ofsuitable therapeutic treatments.
Flow cytometric analysis of cellular DNA content has become
an increasingly important clinical tool forthe evaluation oftumour
biological behaviour. Quantitative DNA analysis reflects the total
chromosomal content of tumour cells. In terms of the cell nuclear
DNA content of HCC, it has been reported (Fujimoto et al, 1991;
Chiu et al, 1992) that an aneuploid DNA pattern indicates poor
prognosis. With regard to the heterogeneity of the DNA ploidy
pattern, HCC has been reported to be mostly homogeneous within
the same tumour (Kuo et al, 1987; Nagasue et al, 1993; Ng et al,
1994). However, there have been few studies on the heterogeneity
of DNA content among multiple synchronous HCCs. In the
present study, we investigated tumour DNA heterogeneity in
patients with multiple synchronous HCCs.
MATERIALS AND METHODS
Sixty-two tumours from 26 patients who had undergone surgical
treatment for multiple HCCs at the First Department of Surgery,
Shinshu University Hospital, between October 1989 and August
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1994, were studied. Two patients each had four tumours, six
patients had three tumours and the remaining 18 patients had two
tumours each. There were 17 men and nine women with a mean age
of64.5 ± 6.3 (s.d.) years (range, 54-82 years). In all patients, histo-
logical examination of the non-cancerous tissue demonstrated
chronic hepatitis, precirrhosis or cirrhosis. Three patients were
positive for hepatitis B virus, 22 patients for hepatitis C virus and
one patient for both viruses. The tumour size ranged from 0.6 to
6.0 cm with an average of 2.4 ± 1.1 cm (mean ± s.d.). These 62
tumours in the present study were considered to be of potentially
multifocal origin as they did not meetthe following criteria ofintra-
hepatic metastasis: multiple HCCs were diagnosed as metastatic in
origin from a single tumour (a) when they were components of
portal vein tumour thrombi, i.e. tumours apparently growing in
contiguity with portal vein tumour thrombi or (b) when they were
distributed as multiple small-satellite nodules surrounding a large
main tumour (Kanai et al, 1987; Odaet al, 1992; Tsuda et al, 1992).
A cell nucleus suspension was obtained from a paraffin-
embedded block of a surgically resected specimen, following the
methods of Hedley with some modifications (Hedley et al, 1983;
Hui et al, 1994). Briefly, the tumour and non-tumour parts were
obtained from resected specimens. Three 50-gm-thick sections
were cut, in addition to a 5-gm-thick section before and after each
series of50-gm-thick sections. The 5-gm-thick section was stained
with haematoxylin and eosin in order to evaluate the pathological
features and to assess the tumour area in the section, then accord-
ingly, the tumour was trimmed from the 50-gm-thick section. The
tissue was dewaxed, rehydrated and then digested with pepsin. The
isolated nuclei were stained according to the method described
previously (Vindel0v et al, 1983). Cell nuclear DNA content was
analysed using aFACScan (Becton Dickinson, Mountain View, CA,
USA) with Cellfit doublet discriminator software. The histogram
was derived from up to 15 000 cells. The instrument was calibrated
with chicken erythrocyte nuclei. As external controls, sections from
non-tumour liver within the same surgical specimen were processed
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Figure 1 DNA ploidy pattern. Three patterns of nuclear DNA ploidy status were classified. Pattern 1, diploidy (DNA index from 0.9 to 1.1) (A). Pattern 11,
aneuploidy with one GIG1 peak, either hypoploidy (DNA index <0.9) (B) or hyperploidy (DNA index> 1.1) (C). Pattern III, aneuploidy with more than one
GIG1 peak (D)
simultaneously with the tumour sample, and the DNA index (DI)
was calculated according to the standard method (Hiddemann et al,
1984). Tumours with a DI of0.9-1.1 were recorded as diploid, and
those with a DI ofmore than 1.1 or less than 0.9 as aneuploid. The
DNA ploidy status of the tumour was classified into three patterns
(Chiu et al, 1992): pattern I, tumours with a diploid DNA distribu-
tion; pattern II, tumours with an aneuploid DNA content and
containing only oneprominentGJG, peak; pattern III, tumours with
an aneuploid DNA content and containing > 1 GJG1 peaks (Figure
1). Heterogeneity of DNA content among multiple tumours was
recognized when tumours had different DNA ploidy patterns or
when the difference in the DI of an aneuploid clone exceeded 0.1,
even though the tumours belonged to the same pattern II or pattern
HI. The coefficient of variation (CV) of the diploid GJG1 peak
ranged from 3.5% to 8.7% (mean ± s.d., 5.53 ± 1.35%).
RESULTS
The results of histological and flow cytometric studies of the 62
tumours from 26 patients with multiple synchronous HCCs are
summarized in Table 1. The tumours had atrabecularpattern in 53
cases (85.5%), a compact pattern in six (9.7%), a pseudoglandular
pattern in two (3.2%) and a solidpattern in one (1.6%). Among the
26 patients, six (23.1%) had heterogeneous and 20 (76.9%) had
homogeneous histological type among the multiple tumours.
Regarding the grade of tumour differentiation, 20 tumours
(32.3%) were well differentiated, 33 (53.2%) were moderately
differentiated and nine (14.5%) were poorly differentiated. The
histological type and the grades of differentiation among the
multiple tumours were identical in 9 of the 26 cases and different
in the remaining 17. A tumour with aneuploid DNA was observed
in 17 (65.4%) of the 26 patients. Among the 62 tumours, 35
(56.4%) were diploid (pattern I) and 27 (43.5%) were aneuploid,
ofwhich 14 tumours belonged topattern II and theremaining 13 to
pattern III. DNA heterogeneity among multiple tumours was
observed in 12 out of 26 patients (46.2%, cases 15-26), among
which the DNA content difference represented the diploid-aneu-
ploid type in ten (cases 17-26). In cases 15 and 16, the difference
in DI of the aneuploid clone was more than 0.1, although both of
the tumours were aneuploid (pattern III). Of the 12 patients with
tumours showing DNA heterogeneity, seven (58.3%) had the
heterogeneous (cases 15, 18, 19, 20, 23, 24 and 26) and the
remaining five (41.7%) had the homogeneous histological type
and grade oftumour differentiation.
DISCUSSION
Quantitative DNA analysis reflects the total chromosomal content
of tumour cells and it can now be conducted rapidly and reliably
using flow cytometry. Flow cytometric DNA analysis has become
a valuable adjunct to the clinical and histopathological assessment
ofcancers.
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Table 1 Histopathological features and DNA content in multiple hepatocellular carcinoma
Histological Differentiation DNA analysis Histological type Differentiation DNA content
Case Tumour type heterogeneity heterogeneity heterogeneity
Pattem CV(%) Dl
Trabecular Well
Trabecular Well
Trabecular Well
Trabecular Well
Trabecular Well
Trabecular Moderate
Trabecular Well
Trabecular Well
Trabecular Moderate
Trabecular Moderate
Trabecular Moderate
Trabecular Poor
Trabecular Moderate
Trabecular Moderate
Trabecular Moderate
Solid Poor
Trabecular Well
Trabecular Well
Trabecular Moderate
Trabecular Moderate
Trabecular Moderate
Trabecular Moderate
Trabecular Well
Trabecular Well
Pseudoglandular Moderate
Compact Poor
Trabecular Poor
Trabecular Well
Trabecular Moderate
Compact Moderate
Trabecular Moderate
Trabecular Moderate
Trabecular Moderate
Trabecular Moderate
Trabecular Well
Trabecular Moderate
Trabecular Moderate
Compact Poor
Compact Poor
Trabecular Moderate
Trabecular Well
Trabecular Well
Trabecular Poor
Trabecular Well
Trabecular Well
Trabecular Well
Trabecular Well
Trabecular Moderate
Trabecular Moderate
Trabecular Moderate
Trabecular Moderate
Trabecular Moderate
Pseudoglandular Moderate
Trabecular Moderate
Trabecular Well
Trabecular Moderate
Trabecular Moderate
Trabecular Moderate
Trabecular Moderate
Trabecular Moderate
Compact Poor
Compact Poor
11
I
I1
I1
I1
I1
I1
I1
I1
Il
Il
Il
Il
Il
Il
I1
II
II
II
II
Ill
Ill
111
111
111
I1
11
11
11
11
11
111
111
111
III
III
111
6.8 1.00
3.6 1.00
6.1 1.02
5.4 1.02
4.2 1.05
4.6 1.02
3.5 1.02
5.8 1.08
7.3 1.03
7.6 1.06
6.1 1.03
5.4 1.03
4.0 0.98
4.5 0.95
6.7 1.01
5.4 1.01
7.5 1.02
7.5 0.96
6.4 1.06
4.2 1.10
5.8 1.04
4.2 1.08
4.8 0.94
3.9 1.22
5.9 1.31
6.5 1.14
4.5 1.16
4.7 1.19
4.3 1.15
4.6 1.18
4.7 1.18
5.3 1.29
4.6 1.19
5.2 1.22
6.4 1.35
8.7 1.24
4.2 1.43
3.5 0.97
8.4 1.11
5.8 0.95
7.3 0.82
4.9 0.96
4.7 0.93
7.0 0.80
4.6 1.06
4.9 1.13
4.3 1.22
6.1 0.94
7.3 0.79
8.1 0.94
5.9 2.16
5.6 0.91
6.9 1.36
7.5 0.99
6.0 1.46
5.0 1.01
7.0 1.05
4.6 1.25
6.5 0.93
8.1 0.82
4.8 1.77
6.3 1.93
No
No
No
No
No
No
Yes
No
No
No
No
Yes
Yes
Yes
No
Yes
No
No
No
No
No
No
No
No
Yes
Yes Yes
Yes No
No Yes
Yes
No
No
No
No
No
No
No
No
No
No
No
Yes
No
Yes
No
No
Yes
No
No
Yes
Yes
No
Yes
Yes
No
Yes
Yes
No
Yes
No
No
Yes
No
Yes
Yes
No
No
Yes
Yes
No
Yes
No
Yes
Yes
Yes Yes
IDNA ploidy pattern; CV, coefficient of variation; DI, DNA index; T, tumour.
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Although intratumoral heterogeneity of DNA content has been
observed in carcinomas of various organs (Vindel0v et al, 1980;
Quirke et al, 1983; Ljungberg et al, 1985; Sasaki et al, 1988;
Sasaki et al, 1991), HCC is generally thought to be homogeneous
within the tumour in terms of DNA content (Kuo et al, 1987;
Nagasue et al, 1993; Ng et al, 1994), indicating that single
sampling is sufficient for deciding the DNA ploidy pattern in
patients with solitary HCC. In the present study, three 50-gm
sections were prepared for flow cytometry procedures.
Considering that materials are usually taken by one-site sampling
in studies using fresh tissue, the results obtained from paraffin-
embedded blocks, as in the present study, are considered more
representative of the whole tumour than those from fresh
materials, at least in terms ofDNA content.
It has been shown that DNA content analysis is an important
predictor ofprognosis, which is better in diploid than in aneuploid
tumours (Fujimoto et al, 1991; Chiu et al, 1992), although some
authors have suggested that the advanced tumour stage of large
lesions may negate the influence of DNA ploidy status on patient
outcome (McEntee et al, 1992). These studies were limited to
analysis ofa single tumour nodule in patients with HCC. However,
multiple HCCs occurin some cases. Heterogeneity ofDNA content
between different nodules, if present, may influence the DNA
content status for predicting prognosis. In the present investigation,
it was demonstrated that heterogeneity of DNA content among
different tumour nodules occurred in 46% ofsynchronous multiple
HCCs, indicating thatanalysis ofthe DNA content ofevery tumour
is necessary for determing the prognosis in this disease.
Heterogeneity of DNA content in synchronous multiple HCCs
has been demonstrated previously by Feulgen DNA analysis (Kuo
et al, 1987) and flow cytometric DNA analysis (Nagasue et al,
1992). Unfortunately, however, the number of cases investigated
was limited (14 cases in each study). The incidence of hetero-
geneity was 29% in the former study and 36% in the latter, which
was lower than in our study (46%). There are two possible reasons
for the discrepancy between the previous studies and ours. First,
the previous studies included only patients with two tumour
nodules, whereas in our study eight patients had more than two
nodules. Second, the previous studies investigated heterogeneity
simply by classifying tumours as either diploid or aneuploid
(Nagasue et al, 1992), or by roughly comparing their DNA ploidy
profiles (Kuo et al, 1987). By contrast, in the present study, hetero-
geneity ofDNA content was considered not only when a different
DNA ploidy pattern was observed, but also when a different DI
(difference > 0.1) was demonstrated among the tumours with an
aneuploid pattern.
Heterogeneity by histological criteria (histological type and
grade of tumour differentiation) was observed in 16 (62%) of the
26 patients with synchronous multiple HCCs, and there seemed to
be no relationship between heterogeneity of histological appear-
ance and DNA content (Table 1).
Genetic and/or chromosomal analyses have demonstrated that
solitary HCCs are ofmonoclonal origin (Esumi et al, 1986; Aihara
et al, 1996). On the other hand, the clonal origin ofmultiple HCCs
has been classified conventionally as multifocal or metastatic, i.e.
polyclonal or monoclonal, based mainly on macro- and micro-
scopic features. However, it has usually been difficult to determine
clonal origin in clinical practice. Integrated HBV DNA has been
used as a marker of HCC clonality, but this is applicable only to a
portion of patients who have hepatitis B virus infection (Esumi et
al, 1986; Tsuda et al, 1988; Sakamoto et al, 1989; Hsu et al, 1991).
In our present series, only four patients harboured hepatitis B
virus. Recently, examinations of chromosal allele loss patterns
(Tsuda et al, 1992) and patterns of p53 gene mutation (Oda et al,
1992) have been reported to be useful for diagnosis of multifocal
HCC. However, these methods are not totally ideal because p53
gene mutation and chromosal allele loss were detected in only
60-70% ofmultiple HCCs. These findings showed thatjudgement
of the origin of multiple HCCs should be made on a comprehen-
sive basis, taking into acount both morphology and other criteria
such as DNA content.
Assuming that single HCCs are monoclonal and that their DNA
content remains homogeneous during tumour growth, the differ-
ence in DNA content among multiple tumours strongly indicates
their different clonal origin. However, analysis of DNA content
must be considered limited, as it only reflects the chromosomal
content of tumour cells, and a cell with a balanced gain or loss of
chromosomes, or with structural rearrangements, will not be
detected. Also, it can notgive conclusive information on the clonal
origin in cases showing a homogeneous DNA pattern, as tumours
of different clonal origin may well present the same DNA ploidy
pattern. In our series of multiple HCCs, multifocal origin was
identified in 12 (46%) ofthe 26 patients by quantitative analysis of
DNA content. In the remaining 14 (56%) cases in which the DNA
content was homogeneous among the tumours, their clonal origin
still remained undetermined. Comparing the various genetic
methods for analysis of multifocal HCC, quantitative analysis of
DNA content seems less specific, but it is simple and technically
convenient. In order to estimate the value of quantitative DNA
content analysis for deciding the clonal origin of multiple HCCs,
further investigations such as comparative studies of genetic
methods in a single series of patients with synchronous multiple
HCCs will be necessary.
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